Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Medical Developments International Limited ( (AU:MVP) ).
Medical Developments International Limited announced a change in the director’s interest, with Director Russell Basser acquiring 40,000 fully paid ordinary shares, increasing his total holdings to 55,873 shares. This acquisition, conducted through an on-market trade, reflects a significant investment by the director, potentially indicating confidence in the company’s future prospects and stability, which may positively influence stakeholder perceptions.
The most recent analyst rating on (AU:MVP) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Medical Developments International Limited stock, see the AU:MVP Stock Forecast page.
More about Medical Developments International Limited
Medical Developments International Limited operates in the healthcare industry, focusing on the development and distribution of medical products. Its primary offerings include pain relief solutions and respiratory devices, catering to both domestic and international markets.
Average Trading Volume: 126,227
Technical Sentiment Signal: Buy
Current Market Cap: A$78.86M
Find detailed analytics on MVP stock on TipRanks’ Stock Analysis page.